Neuberger Berman Group »

Dianthus Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.6M 88k 41.21

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jan28 Now P @ 120.000000 Option Put Option (NOW)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
February 26 Calls on HD US Option Call Option (HD)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Ishares Core S&p 500 Etf Etf (IVV)
Nextera Energy Common (NEE)
Visa Inc-class A Shares Common (V)

View all positions for Neuberger Berman Group

Top funds holding Dianthus Therapeutics

FMR
RA Capital Management
Wellington Management Company
Octagon Capital Advisors
Fairmount Funds Management
Avidity Partners Management
Vanguard Group
BlackRock
TCG Crossover Management
State Street Corporation
Braidwell
Point72 Asset Management
Citadel Advisors
Marshall Wace
Polar Capital Holdings

View all funds holding Dianthus Therapeutics